StockData
MapLight Therapeutics, Inc. logo

MapLight Therapeutics, Inc. (MPLT) KPIs and segments

MPLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$6.57−0.33 (-4.78%)

Close on Nov 17, 2026Market cap $304.70MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive MapLight Therapeutics's business

Coming soon

This tab will track the numbers specific to MapLight Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?